SciSparc Ltd. (NASDAQ:SPRC) Short Interest Update

SciSparc Ltd. (NASDAQ:SPRC) was the recipient of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 155,400 shares, an increase of 61.9% from the November 30th total of 96,000 shares. Based on an average daily volume of 725,400 shares, the days-to-cover ratio is currently 0.2 days. Currently, 1.5% of the shares of the company are sold short.

SciSparc Stock Down 14.2 %

SPRC stock traded down $0.07 during trading on Friday, hitting $0.43. 8,035,851 shares of the company’s stock traded hands, compared to its average volume of 2,476,734. SciSparc has a 52 week low of $0.20 and a 52 week high of $6.78. The stock has a fifty day moving average price of $0.24 and a two-hundred day moving average price of $0.39.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in SciSparc stock. Renaissance Technologies LLC bought a new position in SciSparc Ltd. (NASDAQ:SPRC) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 39,700 shares of the company’s stock, valued at approximately $32,000. Renaissance Technologies LLC owned 5.59% of SciSparc at the end of the most recent reporting period. Institutional investors and hedge funds own 25.06% of the company’s stock.

About SciSparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.